The Role of Liver-directed Surgery in Patients with Hepatic Metastasis from a Gynecologic Primary Carcinoma

[1]  T. Chua,et al.  Salvage cytoreduction for chemorefractory ovarian cancer with peritoneal carcinomatosis: A last chance or futile efforts? , 2010, The Australian & New Zealand journal of obstetrics & gynaecology.

[2]  G. Kenter,et al.  Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. , 2010, The New England journal of medicine.

[3]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[4]  M. Choti,et al.  Safety and efficacy of curative intent surgery for peri‐ampullary liver metastasis , 2010, Journal of surgical oncology.

[5]  A. Cucchetti,et al.  The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. , 2009, Minerva chirurgica.

[6]  A. Lopes,et al.  Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma. , 2009, European journal of obstetrics, gynecology, and reproductive biology.

[7]  Ping Wang,et al.  Prognostic analysis of ovarian cancer patients using the Cox regression model. , 2009, Ai zheng = Aizheng = Chinese journal of cancer.

[8]  M. Shoup,et al.  Hepatic resection for recurrent metastatic ovarian cancer. , 2008, American journal of surgery.

[9]  U. Güth,et al.  Metastatic patterns at autopsy in patients with ovarian carcinoma , 2007, Cancer.

[10]  J. Seidman,et al.  Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening , 2007, International Journal of Gynecologic Cancer.

[11]  E. Abdalla,et al.  Patient selection and outcome of hepatectomy for noncolorectal non-neuroendocrine liver metastases. , 2007, Surgical oncology clinics of North America.

[12]  M. Choti,et al.  Liver-Directed Surgery for Metastatic Squamous Cell Carcinoma to the Liver: Results of a Multi-Center Analysis , 2007, Annals of Surgical Oncology.

[13]  J. McAlpine,et al.  Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. , 2007, Gynecologic oncology.

[14]  Jeffrey H Silber,et al.  Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  P. Kuo,et al.  Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. , 2007, Journal of the American College of Surgeons.

[16]  C. H. Lai,et al.  0749: Prognostic Factors and Adjuvant Therapy in Uterine Carcinosarcoma , 2006, International Journal of Gynecologic Cancer.

[17]  D. Jaeck,et al.  Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases: Analysis of 1452 Patients and Development of a Prognostic Model , 2006, Annals of surgery.

[18]  T. Pawlik,et al.  Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. , 2006, Archives of surgery.

[19]  E. D. de Vries,et al.  Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma , 2006, Cancer.

[20]  V. Georgoulias,et al.  Major hepatectomy and right hemicolectomy at the time of primary cytoreductive surgery for advanced ovarian cancer: report of a case. , 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[21]  A. Nair,et al.  Single cystic liver metastasis in residual carcinoma of the uterine cervix. , 2005, European journal of obstetrics, gynecology, and reproductive biology.

[22]  Y. Taketani,et al.  Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection , 2005, British Journal of Cancer.

[23]  S. Rubin,et al.  Secondary surgical cytoreduction for advanced ovarian carcinoma. , 2004, The New England journal of medicine.

[24]  M. Reeves,et al.  Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: case report and literature review. , 2004, Gynecologic oncology.

[25]  J. Kavanagh,et al.  Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review , 2004, International Journal of Gynecologic Cancer.

[26]  R. Barakat,et al.  Resection of recurrent ovarian or fallopian tube carcinoma involving the liver. , 2003, Gynecologic oncology.

[27]  I. Vergote,et al.  The role of interval debulking surgery in ovarian cancer , 2003, Current oncology reports.

[28]  T. Lesnick,et al.  Hepatic resection for metachronous metastases from ovarian carcinoma. , 2003, Gynecologic oncology.

[29]  C. Rossi,et al.  Distant metastases in ovarian carcinoma , 2002, International Journal of Gynecologic Cancer.

[30]  W. Jarnagin,et al.  Major hepatectomy at interval debulking for stage IV ovarian carcinoma: a case report. , 2002, Gynecologic oncology.

[31]  Y. N. Park,et al.  Hepatic resection of metastatic tumor from serous cystadenocarcinoma of the ovary. , 2002, Journal of Korean medical science.

[32]  R. Herrera-Goepfert,et al.  Resection of liver metastases from a virilizing steroid (lipoid) cell ovarian tumor. , 2002, Hepato-gastroenterology.

[33]  C. Meltzer,et al.  Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. , 2002, Gynecologic Oncology.

[34]  P. Bizouarn,et al.  Hepatic resections for non-colorectal metastases: forty resections in 35 patients. , 2000, Hepato-gastroenterology.

[35]  Q. Liu,et al.  Cytoreductive surgery for stage IV epithelial ovarian cancer. , 1999, Journal of experimental & clinical cancer research : CR.

[36]  M. Cuesta,et al.  Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. , 1999, Annals of surgery.

[37]  R. Campani,et al.  Spontaneous Hemorrhage of a Liver Metastasis from Squamous Cell Cervical Carcinoma: Case Report and Review of the Literature , 1999, Tumori.

[38]  B. Karlan,et al.  Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. , 1999, Gynecologic oncology.

[39]  M. Gore,et al.  Natural history of stage IV epithelial ovarian cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  J. Nesland,et al.  An evaluation of prognostic factors in uterine carcinosarcoma. , 1997, Gynecologic oncology.

[41]  R. Barakat,et al.  Hepatic resection for metastatic gynecologic carcinomas. , 1997, Gynecologic oncology.

[42]  M. Brennan,et al.  Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. , 1997, Surgery.

[43]  P. V. van Dam,et al.  Ultraradical debulking of epithelial ovarian cancer with the ultrasonic surgical aspirator: a prospective randomized trial. , 1996, American journal of obstetrics and gynecology.

[44]  M. Buyse,et al.  The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. , 1995, The New England journal of medicine.

[45]  E. Felip,et al.  Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment. , 1994, Gynecologic oncology.

[46]  N. Teng,et al.  Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. , 1993, Gynecologic oncology.

[47]  J. Thigpen,et al.  The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. , 1992, Gynecologic oncology.

[48]  R. Malt,et al.  Survival after hepatic resection for malignant tumours , 1992, The British journal of surgery.

[49]  R. Berkowitz,et al.  The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma. , 1992, Gynecologic oncology.

[50]  T. Inoue,et al.  Hepatic resection for metastatic squamous cell carcinoma from the uterine cervix. , 1992, Gynecologic oncology.

[51]  M. Piver,et al.  Metastatic patterns in histologic variants of ovarian cancer. An autopsy study , 1989, Cancer.

[52]  N. Hacker,et al.  Distant metastases in epithelial ovarian carcinoma , 1987, Cancer.

[53]  E. Cadman,et al.  Pulmonary metastases in ovarian cancer analysis of 357 patients , 1985, Cancer.

[54]  D. Oram,et al.  Stage III epithelial ovarian cancer: the role of maximal surgical reduction. , 1984, Gynecologic oncology.

[55]  R. Elashoff,et al.  Primary Cytoreductive Surgery for Epithelial Ovarian Cancer , 1983, Obstetrics and gynecology.

[56]  Griffiths Ct.  Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975 .

[57]  K. Lee,et al.  The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer. , 2009, Gynecologic oncology.

[58]  M. Kattan,et al.  Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. , 2008, Gynecologic oncology.

[59]  N. Spirtos,et al.  The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma , 2000, Cancer.

[60]  C. Kosary.  FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. , 1994, Seminars in surgical oncology.

[61]  C. Griffiths.  Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975, National Cancer Institute monograph.

[62]  M. Makuuchi,et al.  Scenario 1 : Complication After a Surgical Procedure Not Caused by a Surgeon , 2022 .